• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNF 受体超家族信号中的聚类优势。

The benefits of clustering in TNF receptor superfamily signaling.

机构信息

Immunobiology Department, Massachusetts General Hospital, Boston, MA, United States.

Harvard Medical School, Boston, MA, United States.

出版信息

Front Immunol. 2023 Aug 17;14:1225704. doi: 10.3389/fimmu.2023.1225704. eCollection 2023.

DOI:10.3389/fimmu.2023.1225704
PMID:37662920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10469783/
Abstract

The tumor necrosis factor (TNF) receptor superfamily is a structurally and functionally related group of cell surface receptors that play crucial roles in various cellular processes, including apoptosis, cell survival, and immune regulation. This review paper synthesizes key findings from recent studies, highlighting the importance of clustering in TNF receptor superfamily signaling. We discuss the underlying molecular mechanisms of signaling, the functional consequences of receptor clustering, and potential therapeutic implications of targeting surface structures of receptor complexes.

摘要

肿瘤坏死因子(TNF)受体超家族是一组结构和功能相关的细胞表面受体,它们在细胞凋亡、细胞存活和免疫调节等各种细胞过程中发挥着关键作用。这篇综述文章综合了最近研究的关键发现,强调了 TNF 受体超家族信号转导中聚集的重要性。我们讨论了信号转导的潜在分子机制、受体聚集的功能后果以及靶向受体复合物表面结构的潜在治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/fc10f71d3f8f/fimmu-14-1225704-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/6116868870b6/fimmu-14-1225704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/c0b35773c497/fimmu-14-1225704-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/8891e75aed0b/fimmu-14-1225704-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/b8b64db8a74f/fimmu-14-1225704-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/fc10f71d3f8f/fimmu-14-1225704-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/6116868870b6/fimmu-14-1225704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/c0b35773c497/fimmu-14-1225704-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/8891e75aed0b/fimmu-14-1225704-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/b8b64db8a74f/fimmu-14-1225704-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5d/10469783/fc10f71d3f8f/fimmu-14-1225704-g005.jpg

相似文献

1
The benefits of clustering in TNF receptor superfamily signaling.TNF 受体超家族信号中的聚类优势。
Front Immunol. 2023 Aug 17;14:1225704. doi: 10.3389/fimmu.2023.1225704. eCollection 2023.
2
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily.受体寡聚化及其与肿瘤坏死因子受体超家族受体信号传导的相关性。
Front Cell Dev Biol. 2021 Feb 11;8:615141. doi: 10.3389/fcell.2020.615141. eCollection 2020.
3
Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily.肿瘤坏死因子受体超家族的受体后信号复合物组装
Adv Protein Chem. 2004;68:225-79. doi: 10.1016/S0065-3233(04)68007-7.
4
TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?HIV 感染中的 TNF 和 TNF 受体超家族成员:新的治疗细胞靶点?
Mediators Inflamm. 2013;2013:484378. doi: 10.1155/2013/484378. Epub 2013 Dec 19.
5
A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations.通过计算模拟对肿瘤坏死因子超家族配体的受体结合动力学进行系统测试。
Int J Mol Sci. 2020 Mar 5;21(5):1778. doi: 10.3390/ijms21051778.
6
A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.肿瘤坏死因子受体-2及受体相互作用蛋白在程序性坏死和抗病毒反应中的作用
J Biol Chem. 2003 Dec 19;278(51):51613-21. doi: 10.1074/jbc.M305633200. Epub 2003 Oct 7.
7
Analysis of FcγR-Dependent Agonism of Antibodies Specific for Receptors of the Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF).FcγR 依赖性激动剂分析针对肿瘤坏死因子(TNF)受体超家族(TNFRSF)受体的抗体。
Methods Mol Biol. 2021;2248:81-90. doi: 10.1007/978-1-0716-1130-2_6.
8
Structural basis of signal transduction in the TNF receptor superfamily.肿瘤坏死因子受体超家族信号转导的结构基础。
Adv Immunol. 2013;119:135-53. doi: 10.1016/B978-0-12-407707-2.00005-9.
9
On the TRAIL of Better Therapies: Understanding TNFRSF Structure-Function.追寻更好的治疗方法:理解 TNFRSF 的结构与功能。
Cells. 2020 Mar 20;9(3):764. doi: 10.3390/cells9030764.
10
A conserved aromatic moiety in the ectodomain is a key determinant for structural integrity and protein trafficking of TNFR superfamily.细胞外结构域中保守的芳香族部分是 TNFR 超家族结构完整性和蛋白运输的关键决定因素。
FASEB J. 2020 Dec;34(12):15687-15700. doi: 10.1096/fj.202000341R. Epub 2020 Oct 13.

引用本文的文献

1
Comparative Proteomic Analysis of Non-Bleached and Bleached Fragments of the Hydrocoral Reveals Stress Response Signatures Following the 2015-2016 ENSO Event in the Mexican Caribbean.水螅珊瑚未漂白和漂白片段的比较蛋白质组学分析揭示了2015 - 2016年墨西哥加勒比地区厄尔尼诺-南方涛动事件后的应激反应特征。
Biology (Basel). 2025 Aug 13;14(8):1042. doi: 10.3390/biology14081042.
2
The role of tumor necrosis factor receptor superfamily in cancer: insights into oncogenesis, progression, and therapeutic strategies.肿瘤坏死因子受体超家族在癌症中的作用:对肿瘤发生、进展及治疗策略的见解
NPJ Precis Oncol. 2025 Aug 6;9(1):275. doi: 10.1038/s41698-025-00990-x.
3

本文引用的文献

1
Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity.基于抗体的可溶性和膜结合 TWEAK 模拟激动剂,具有 FcγR 非依赖性活性。
Front Immunol. 2023 Jul 11;14:1194610. doi: 10.3389/fimmu.2023.1194610. eCollection 2023.
2
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives.提供共刺激肿瘤坏死因子受体激动剂用于癌症免疫治疗:过去、现在和未来的观点。
Front Immunol. 2023 Apr 25;14:1147467. doi: 10.3389/fimmu.2023.1147467. eCollection 2023.
3
Reducing affinity as a strategy to boost immunomodulatory antibody agonism.
Structural elucidation of the haptoglobin-hemoglobin clearance mechanism by macrophage scavenger receptor CD163.
巨噬细胞清道夫受体CD163介导的触珠蛋白-血红蛋白清除机制的结构解析
PLoS Biol. 2025 Jul 11;23(7):e3003264. doi: 10.1371/journal.pbio.3003264. eCollection 2025 Jul.
4
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering.INBRX-106:一种六价OX40激动剂,通过优化受体聚集驱动卓越的抗肿瘤反应。
J Immunother Cancer. 2025 May 21;13(5):e011524. doi: 10.1136/jitc-2025-011524.
5
Immune inhibitory receptor agonist therapeutics.免疫抑制受体激动剂疗法。
Front Immunol. 2025 Mar 26;16:1566869. doi: 10.3389/fimmu.2025.1566869. eCollection 2025.
6
Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors.利用DNA纳米结构介导的死亡受体超聚集诱导癌细胞杀伤
Nano Lett. 2025 Apr 16;25(15):6310-6317. doi: 10.1021/acs.nanolett.5c01122. Epub 2025 Apr 8.
7
CD163, a novel receptor for TNF, was revealed by proximity ligation assay.通过邻近连接分析揭示了CD163,一种肿瘤坏死因子的新型受体。
Heliyon. 2025 Feb 1;11(3):e42194. doi: 10.1016/j.heliyon.2025.e42194. eCollection 2025 Feb 15.
8
Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 molecule.通过精确确定表位并利用CD30分子的结构特征,从一种激动性抗体生成拮抗性双表位抗CD30抗体。
Antib Ther. 2025 Jan 14;8(1):56-67. doi: 10.1093/abt/tbaf002. eCollection 2025 Jan.
9
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes.可激活T淋巴细胞上OX40的OX40配体融合蛋白的产生与特性分析
Front Immunol. 2025 Jan 10;15:1473815. doi: 10.3389/fimmu.2024.1473815. eCollection 2024.
10
Turn TRAIL Into Better Anticancer Therapeutic Through TRAIL Fusion Proteins.通过TRAIL融合蛋白将TRAIL转化为更好的抗癌治疗药物。
Cancer Med. 2025 Jan;14(1):e70517. doi: 10.1002/cam4.70517.
降低亲和力作为增强免疫调节抗体激动作用的策略。
Nature. 2023 Feb;614(7948):539-547. doi: 10.1038/s41586-022-05673-2. Epub 2023 Feb 1.
4
Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking.用于癌症免疫治疗的抗体靶向肿瘤坏死因子受体超家族激活:FcγRIIB交联的作用
Front Pharmacol. 2022 Jul 5;13:924197. doi: 10.3389/fphar.2022.924197. eCollection 2022.
5
Hinge disulfides in human IgG2 CD40 antibodies modulate receptor signaling by regulation of conformation and flexibility.铰链二硫键在人 IgG2 CD40 抗体中通过调节构象和柔韧性来调节受体信号转导。
Sci Immunol. 2022 Jul 15;7(73):eabm3723. doi: 10.1126/sciimmunol.abm3723. Epub 2022 Jul 8.
6
Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment.超分辨率成像技术揭示了膜结合型 Fas 配体诱导的 Fas/CD95 重排过程中,FADD 募集的上游存在纳米级簇集。
Cells. 2022 Jun 12;11(12):1908. doi: 10.3390/cells11121908.
7
An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy.抗 PD-1-GITR-L 双特异性激动剂诱导 GITR 聚类介导的 T 细胞激活用于癌症免疫治疗。
Nat Cancer. 2022 Mar;3(3):337-354. doi: 10.1038/s43018-022-00334-9. Epub 2022 Mar 7.
8
Munc13 structural transitions and oligomers that may choreograph successive stages in vesicle priming for neurotransmitter release.Munc13 结构的转变和寡聚体可能在神经递质释放的囊泡引发的连续阶段中进行协调。
Proc Natl Acad Sci U S A. 2022 Feb 15;119(7). doi: 10.1073/pnas.2121259119.
9
Signal Amplification in Highly Ordered Networks Is Driven by Geometry.高度有序网络中的信号放大是由几何形状驱动的。
Cells. 2022 Jan 13;11(2):272. doi: 10.3390/cells11020272.
10
Nanoscale FasL Organization on DNA Origami to Decipher Apoptosis Signal Activation in Cells.基于 DNA 折纸的纳米 FasL 组织化以解析细胞中的凋亡信号激活
Small. 2021 Jul;17(26):e2101678. doi: 10.1002/smll.202101678. Epub 2021 May 31.